Trxade Health Inc (NASDAQ: MEDS) stock closed at $4.14 on 1/14/25 after a major decline of -11.0%. Moreover, unusually high trading volume at 191% of normal accompanied the decline. The stock has declined -31.6% during the last week and has been weak relative to the market over the last nine months.
Current PriceTarget Research Rating
Trxade Health has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing complementary signals. Trxade Health has a slightly negative Power Rating of 37 and a very low Appreciation Score of 3, with the Lowest Value Trend Rating the result.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment